Karen Liu, Managing Director at 3E Bioventures, Beijing, Beijing, China — verified investor profile. See sector focus and contact routes.
3E Bioventures Capital is a life science focused VC fund, actively investing in global leading health innovators. They invest in Biotech (new drugs, new modalities, and drug discovery platforms) and in TechBio, which is the intersection of biology and technology. 3E Bioventures employs a science-driven, entrepreneur-friendly investment philosophy, collaborating with companies and research institutions to develop drugs or products addressing unmet medical needs.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Beijing when building a target list.
Investors like Karen Liu · Full investor directory · Investor access · Company funding database